前列腺切除术
前列腺癌
多西紫杉醇
医学
肿瘤科
激素疗法
雄激素剥夺疗法
新辅助治疗
随机对照试验
临床终点
抗雄激素
泌尿科
内科学
癌症
乳腺癌
作者
Hongyang Qian,Chenfei Chi,Thibault Tricard,Yinjie Zhu,Liang Dong,Yanqing Wang,Jianjun Sha,Jiayi Wang,Zehua Ma,Yan Wang,Jiazhou Liu,Baijun Dong,Jiahua Pan,Wei Xue
标识
DOI:10.1097/ju.0000000000003876
摘要
Benefits of docetaxel-based neoadjuvant chemohormonal therapy (NCHT) before radical prostatectomy (RP) remain largely unknown. We explored whether docetaxel-based NCHT would bring pathological benefits and improve biochemical progression-free survival (bPFS) over neoadjuvant hormonal therapy (NHT) in locally advanced prostate cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI